The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 471.00
Bid: 471.00
Ask: 471.50
Change: -3.00 (-0.63%)
Spread: 0.50 (0.106%)
Open: 476.50
High: 478.00
Low: 466.00
Prev. Close: 474.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Apr 2021 07:00

RNS Number : 0398V
Treatt PLC
12 April 2021
 

12 April 2021

 

TREATT PLC

("Treatt" or "the Group")

 

Half Year Trading Update

 

Momentum continues with strong growth in revenue and margins

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today publishes a trading update for the half year ended 31 March 2021 (the "Period").

 

Highlights

 

· Strong performance across all categories with revenue expected to grow by 14% to approximately £60.8m (H1 2020: £53.6m).

· Growth particularly strong in tea, health & wellness and fruit & vegetables categories meeting growing global consumer demand for healthier living.

· Gross margin improvements reflect the growth of the above categories and the transition into more sophisticated, solution-driven products in citrus.

· New, state-of-the-art, UK headquarters opening April 2021 with colleagues beginning to transition on a phased basis, which, along with the recently expanded US facility, ensures the Group is well-positioned for future growth.

· Trading in line with the Board's revised expectations as announced in January 2021.

 

Trading performance

 

Following the trading update announced in January 2021, the Board is pleased to confirm that momentum has continued across the business. Expected revenue growth for the half year of 14% (16% in constant currency) has been driven by the Group's fast-growing and higher margin categories of tea, health & wellness and fruit & vegetables. These categories in particular meet the growing demand from consumers for more natural, clean-label and 'better-for-you' beverages and are driving pipeline growth and, in turn, our financial performance.

 

During the Period the Group has won significant new business across a wide range of beverage and flavour applications including the fast-growing alcoholic seltzer market which continues to expand rapidly in the US and begins to gain traction globally. Revenue growth has been achieved through direct sales to global and local brand owners as well as indirectly through the flavour and fragrance industry, demonstrating the strength of the Group's business model.

 

Citrus revenue has returned to modest growth, following a decline in FY20, and margins improved materially in the Period as the Group's prior investment in more sophisticated extraction technologies resulted in the launch of more value-add ingredients. In addition, raw material prices for orange oil, which fell significantly in 2019, have returned to more normalised levels.

 

The Group continues to grow its synthetic aroma business. This category, which includes important flavour ingredients for meat alternative protein flavours and snack foods, performed well with revenue up significantly compared with the prior year. Herbs, spices & florals, which include an extensive range of manufactured and traded essential oils and extracts, saw revenues fall in the Period due to reduced demand caused by Covid-19.

 

Work on our new UK facility continues apace and we are now a significant way through the operational fit out. We will begin transitioning colleagues across in late April 2021 and will start the commissioning of the new plant and machinery later this calendar year as planned, to enable production to relocate. We believe this site, along with our recently expanded US facility, will provide Treatt with a much stronger platform to support its growth ambitions.

 

With the UK relocation nearing completion, net debt at the end of the Period was £5.1m with total bank facilities of £21.2m remaining undrawn.

 

Whilst the Group's hedging strategy is intended to mitigate the impact of exchange rate movements, there can be material effects in the short term. During the Period there was a strengthening of Sterling against the US Dollar and, as a result, the Board anticipates a net positive FX impact on the results for the Period of approximately £0.4m.

 

Outlook

 

As reported in our January 2021 trading update, the financial year began strongly in terms of both revenue and margins; this momentum has continued throughout H1, with trading in line with the Board's revised expectations. April 2021 is on track to be another strong month for the Group and performance in the second half should be bolstered by increased demand for the Group's diverse range of natural extracts as hospitality venues, including sports stadia, gradually open.

 

It is currently expected that Treatt's half year results for the six months ended 31 March 2021 will be announced on 11 May 2021, when a further update will be provided based on performance to 30 April 2021 and the outlook for the rest of the year.

 

Daemmon Reeve, CEO, commented:

 

"Performance across the Group continues to be very strong despite the ongoing global Covid-19 related restrictions. These measures continue to impact our customers in global hospitality industries and whilst the outlook is promising, we are taking a conservative approach and will assess how our order book progresses in the coming weeks and months. The success we have had in diversifying the Group's flavour and fragrance expertise across a wide range of categories has helped our resilience over the Period.

 

Our strategy is driven by an obsession with offering solutions that are of clear relevance to our customer base, providing differentiated ingredients that align with consumer trends in growing markets. Our effectiveness in developing these relationships continues to shine through and the execution is testament to the skill and endeavour of our colleagues together with the culture across the Group."

 

 

Enquiries:

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Joint Brokers

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

Alex Wright

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Andrew Clark

Will Bell

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Simon Hockridge

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

 

For further information about the Group, visit www.treatt.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVESSIAIIL
Date   Source Headline
20th May 20147:00 amRNSHalf Year Results
19th May 20149:47 amRNSVoting Rights and Capital
16th May 201412:07 pmRNSResult of EGM
16th Apr 20141:41 pmRNSNotice of EGM
9th Apr 20142:34 pmRNSDirector/PDMR Shareholding
7th Apr 201410:56 amRNSNotice of EGM
24th Feb 20145:12 pmRNSResult of AGM
10th Feb 20147:00 amRNSInterim Management Statement
31st Dec 20137:00 amRNSAnnual Information Update
23rd Dec 20134:35 pmRNSDirector/PDMR Shareholding
19th Dec 201310:32 amRNSAnnual Financial Report
13th Dec 20139:48 amRNSDirector/PDMR Shareholding
9th Dec 20137:00 amRNSFinal Results
22nd Oct 20134:22 pmRNSDirector/PDMR Shareholding
17th Oct 20132:53 pmRNSDirector/PDMR Shareholding
30th Sep 201312:54 pmRNSVoting Rights and Capital
30th Sep 20137:00 amRNSTrading Statement
26th Sep 20133:17 pmRNSDirector/PDMR Shareholding
13th Sep 201310:54 amRNSHolding(s) in Company
3rd Sep 20139:23 amRNSDirector/PDMR Shareholding
1st Aug 20137:00 amRNSInterim Management Statement
31st Jul 20132:14 pmRNSVoting Rights and Capital
29th Jul 201310:48 amRNSDirector/PDMR Shareholding
23rd Jul 20135:01 pmRNSHolding(s) in Company
15th Jul 20133:37 pmRNSDirector/PDMR Shareholding
15th Jul 201310:49 amRNSHolding(s) in Company
12th Jul 201312:50 pmRNSDirector/PDMR Shareholding
10th Jul 20134:31 pmRNSSale of Interest in Treatt plc
10th Jul 20134:28 pmRNSBovill Family Concert Party Placing
31st May 201310:17 amRNSDirector/PDMR Shareholding
28th May 20137:00 amRNSTrading Statement
24th May 201310:54 amRNSDirectorate Change
14th May 201310:56 amRNSDirector/PDMR Shareholding
13th May 20137:00 amRNSInterim Results
2nd Apr 20138:13 amRNSDirector/PDMR Shareholding
28th Mar 201312:58 pmRNSResult of EGM
28th Mar 20137:00 amRNSTrading Update
20th Mar 20137:00 amRNSShareholder Notification Regarding Treatt PLC
19th Mar 20133:16 pmRNSShareholder notification regarding Treatt plc
13th Mar 20137:23 amRNSDirector/PDMR Shareholding
4th Mar 20132:17 pmRNSNotice of EGM
1st Mar 20134:09 pmRNSHolding(s) in Company
1st Mar 201310:02 amRNSNotice of EGM
26th Feb 201310:02 amRNSResult of AGM
18th Feb 20134:18 pmRNSInterim Management Statement
18th Jan 20134:07 pmRNSDirectorate Change
31st Dec 20127:00 amRNSAnnual Information Update
21st Dec 201210:39 amRNSAnnual Financial Report
17th Dec 201211:33 amRNSDirector/PDMR Shareholding
10th Dec 20127:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.